Risk of hypoglycemia in youth with type 2 diabetes on insulin

Madhia Shahid, Gabriel Q. Shaibi, Hayley Baines, Pamela Garcia-Filion, Zoe M Gonzalez Garcia, Micah Olson

Research output: Contribution to journalArticle

Abstract

The objective of this study was to ascertain the risk of hypoglycemia among youth with type 2 diabetes (T2D) on insulin therapy. Twenty-two youth with T2D on insulin therapy (M=12, F=10, age=14.4±4.0 years) were enrolled from a single pediatric endocrine practice. They were followed-up for 3 months with weekly phone calls and monthly in-person visits to review blood glucose logs and document any signs or symptoms of hypoglycemia (defined as finger stick glucose of ≤70 mg/dL). Episodes of hypoglycemia were categorized into five categories: Severe, documented symptomatic, asymptomatic, probable symptomatic and relative hypoglycemia. In addition to examining the risk of hypoglycemia, the degree to which hypoglycemia was associated with patient demographics (e.g. age, gender and body mass index [BMI]) or clinical factors (i.e. duration of diabetes, duration of insulin treatment, glycemic control or insulin dose and regimen) was determined. Nine hypoglycemic events occurred during the study period in five patients with an incidence rate of nine events per 5.3 patient-years. Of the hypoglycemic events, five were symptomatic and four were asymptomatic. No severe hypoglycemic events occurred. Hypoglycemia was not associated with age, ethnicity, duration of insulin treatment, insulin dose or initial hemoglobin (HbA1c). However, a significant difference in BMI was noted, with T2D youth who experienced hypoglycemia having a lower BMI than those who did not experience hypoglycemia. The results of this study suggest that the risk of hypoglycemia in youth with T2D on insulin therapy is low.

Original languageEnglish (US)
Pages (from-to)625-630
Number of pages6
JournalJournal of Pediatric Endocrinology and Metabolism
Volume31
Issue number6
DOIs
StatePublished - Jun 27 2018

Fingerprint

Hypoglycemia
Type 2 Diabetes Mellitus
Insulin
Hypoglycemic Agents
Body Mass Index
Therapeutics
Fingers
Signs and Symptoms
Blood Glucose
Hemoglobins
Demography
Pediatrics
Glucose
Incidence

Keywords

  • hypoglycemia
  • insulin
  • type 2 diabetes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Risk of hypoglycemia in youth with type 2 diabetes on insulin. / Shahid, Madhia; Shaibi, Gabriel Q.; Baines, Hayley; Garcia-Filion, Pamela; Gonzalez Garcia, Zoe M; Olson, Micah.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 31, No. 6, 27.06.2018, p. 625-630.

Research output: Contribution to journalArticle

Shahid, Madhia ; Shaibi, Gabriel Q. ; Baines, Hayley ; Garcia-Filion, Pamela ; Gonzalez Garcia, Zoe M ; Olson, Micah. / Risk of hypoglycemia in youth with type 2 diabetes on insulin. In: Journal of Pediatric Endocrinology and Metabolism. 2018 ; Vol. 31, No. 6. pp. 625-630.
@article{ecd94d8343d94272a2cea0e1c2bea948,
title = "Risk of hypoglycemia in youth with type 2 diabetes on insulin",
abstract = "The objective of this study was to ascertain the risk of hypoglycemia among youth with type 2 diabetes (T2D) on insulin therapy. Twenty-two youth with T2D on insulin therapy (M=12, F=10, age=14.4±4.0 years) were enrolled from a single pediatric endocrine practice. They were followed-up for 3 months with weekly phone calls and monthly in-person visits to review blood glucose logs and document any signs or symptoms of hypoglycemia (defined as finger stick glucose of ≤70 mg/dL). Episodes of hypoglycemia were categorized into five categories: Severe, documented symptomatic, asymptomatic, probable symptomatic and relative hypoglycemia. In addition to examining the risk of hypoglycemia, the degree to which hypoglycemia was associated with patient demographics (e.g. age, gender and body mass index [BMI]) or clinical factors (i.e. duration of diabetes, duration of insulin treatment, glycemic control or insulin dose and regimen) was determined. Nine hypoglycemic events occurred during the study period in five patients with an incidence rate of nine events per 5.3 patient-years. Of the hypoglycemic events, five were symptomatic and four were asymptomatic. No severe hypoglycemic events occurred. Hypoglycemia was not associated with age, ethnicity, duration of insulin treatment, insulin dose or initial hemoglobin (HbA1c). However, a significant difference in BMI was noted, with T2D youth who experienced hypoglycemia having a lower BMI than those who did not experience hypoglycemia. The results of this study suggest that the risk of hypoglycemia in youth with T2D on insulin therapy is low.",
keywords = "hypoglycemia, insulin, type 2 diabetes",
author = "Madhia Shahid and Shaibi, {Gabriel Q.} and Hayley Baines and Pamela Garcia-Filion and {Gonzalez Garcia}, {Zoe M} and Micah Olson",
year = "2018",
month = "6",
day = "27",
doi = "10.1515/jpem-2018-0014",
language = "English (US)",
volume = "31",
pages = "625--630",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "6",

}

TY - JOUR

T1 - Risk of hypoglycemia in youth with type 2 diabetes on insulin

AU - Shahid, Madhia

AU - Shaibi, Gabriel Q.

AU - Baines, Hayley

AU - Garcia-Filion, Pamela

AU - Gonzalez Garcia, Zoe M

AU - Olson, Micah

PY - 2018/6/27

Y1 - 2018/6/27

N2 - The objective of this study was to ascertain the risk of hypoglycemia among youth with type 2 diabetes (T2D) on insulin therapy. Twenty-two youth with T2D on insulin therapy (M=12, F=10, age=14.4±4.0 years) were enrolled from a single pediatric endocrine practice. They were followed-up for 3 months with weekly phone calls and monthly in-person visits to review blood glucose logs and document any signs or symptoms of hypoglycemia (defined as finger stick glucose of ≤70 mg/dL). Episodes of hypoglycemia were categorized into five categories: Severe, documented symptomatic, asymptomatic, probable symptomatic and relative hypoglycemia. In addition to examining the risk of hypoglycemia, the degree to which hypoglycemia was associated with patient demographics (e.g. age, gender and body mass index [BMI]) or clinical factors (i.e. duration of diabetes, duration of insulin treatment, glycemic control or insulin dose and regimen) was determined. Nine hypoglycemic events occurred during the study period in five patients with an incidence rate of nine events per 5.3 patient-years. Of the hypoglycemic events, five were symptomatic and four were asymptomatic. No severe hypoglycemic events occurred. Hypoglycemia was not associated with age, ethnicity, duration of insulin treatment, insulin dose or initial hemoglobin (HbA1c). However, a significant difference in BMI was noted, with T2D youth who experienced hypoglycemia having a lower BMI than those who did not experience hypoglycemia. The results of this study suggest that the risk of hypoglycemia in youth with T2D on insulin therapy is low.

AB - The objective of this study was to ascertain the risk of hypoglycemia among youth with type 2 diabetes (T2D) on insulin therapy. Twenty-two youth with T2D on insulin therapy (M=12, F=10, age=14.4±4.0 years) were enrolled from a single pediatric endocrine practice. They were followed-up for 3 months with weekly phone calls and monthly in-person visits to review blood glucose logs and document any signs or symptoms of hypoglycemia (defined as finger stick glucose of ≤70 mg/dL). Episodes of hypoglycemia were categorized into five categories: Severe, documented symptomatic, asymptomatic, probable symptomatic and relative hypoglycemia. In addition to examining the risk of hypoglycemia, the degree to which hypoglycemia was associated with patient demographics (e.g. age, gender and body mass index [BMI]) or clinical factors (i.e. duration of diabetes, duration of insulin treatment, glycemic control or insulin dose and regimen) was determined. Nine hypoglycemic events occurred during the study period in five patients with an incidence rate of nine events per 5.3 patient-years. Of the hypoglycemic events, five were symptomatic and four were asymptomatic. No severe hypoglycemic events occurred. Hypoglycemia was not associated with age, ethnicity, duration of insulin treatment, insulin dose or initial hemoglobin (HbA1c). However, a significant difference in BMI was noted, with T2D youth who experienced hypoglycemia having a lower BMI than those who did not experience hypoglycemia. The results of this study suggest that the risk of hypoglycemia in youth with T2D on insulin therapy is low.

KW - hypoglycemia

KW - insulin

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85047068018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047068018&partnerID=8YFLogxK

U2 - 10.1515/jpem-2018-0014

DO - 10.1515/jpem-2018-0014

M3 - Article

C2 - 29750653

AN - SCOPUS:85047068018

VL - 31

SP - 625

EP - 630

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - 6

ER -